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Abstract 
Directed capillary ingrowth has long been considered synonymous with tumor vascularization. However, the vascu‑
lature of primary tumors and metastases is not necessarily formed by endothelial cell sprouting; instead, malignant 
tumors can acquire blood vessels via alternative vascularization mechanisms, such as intussusceptive microvascular 
growth, vessel co‑option, and glomeruloid angiogenesis. Importantly, in response to anti‑angiogenic therapies, malig‑
nant tumors can switch from one vascularization mechanism to another. In this article, we briefly review the biological 
features of these mechanisms and discuss on their significance in medical oncology.
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Background
Angiogenesis refers to the proliferation of vascular cells 
(endothelial cells and pericytes) and the increase of vessel 
density. It has a pivotal role in the nutrition of tumors. In 
the 1970s, Folkman et al. [1] found that, without angio-
genesis, solid tumors cannot grow beyond the limits of 
diffusion (1  mm3). Above this size, the so-called angio-
genic switch occurs; currently, anti-angiogenic therapies 
are based on this assumption. In this article, we review 
and compare our data on the vascularization mecha-
nisms of primary and metastatic tumors with the findings 
of other groups. We also discuss the potential reasons for 
failure of anti-angiogenic therapies [2, 3].
Angiogenic processes during vascularization of tumors
The two basic forms of angiogenesis are endothelial 
sprouting [1] and intussusceptive angiogenesis [4]. Both 
processes require connective tissue and participate in 
the formation of the tumor vasculature. Many primary 
tumors (e.g., melanoma, colon cancer, and breast can-
cer) are surrounded by provisional connective tissue that 
develops because of the vascular permeability-enhancing 
effect of vascular endothelial growth factor (VEGF). This 
connective tissue contains fibronectin/fibrin and colla-
gen, which enables the continuous development of new 
capillaries by sprouting or intussusceptive angiogenesis 
[5].
Two models of sprouting angiogenesis have been 
described. According to the first model, interendothe-
lial contacts of the venules closest to the tumors become 
weakened [6]. This phenomenon is caused by angiogenic 
factors released by tumor cells. After local degradation 
of basement membrane, non-polarized endothelial cells 
migrate into the connective tissue. This is followed by the 
formation of the lumen, synthesis of the new basement 
membrane, and the appearance of pericytes around the 
newly formed capillaries. The disadvantage of this model 
is the inability to identify the stimulus required for lumen 
formation.
The second model suggests that interendothelial con-
tacts remain intact, and after the degradation of the 
basement membrane, polarized endothelial cells migrate 
into the connective tissue [7]. During this process, par-
allel migration of polarized endothelial cells enables the 
prompt formation of a split-like lumen that is continuous 
with the lumen of the mother vessel. The basement mem-
brane is continuously deposited by the endothelial cells. 
Only the very tip of the growing capillary bud is free of 
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basement membrane and is in connection with the con-
nective tissue collagen. Migrating along the basement 
membrane deposited by the endothelial cells, proliferat-
ing pericytes of the mother vessel appear later around the 
immature capillaries.
Intussusceptive angiogenesis (i.e., “vessel division”) 
is another mode to increase vessel density. This process 
enhances the complexity and density of the vessel net-
work, thus providing additional surface for further vessel 
sprouting [4]. Intussusceptive angiogenesis increases ves-
sel density faster than sprouting angiogenesis and plays 
a pivotal role in the formation of the developing lung 
vasculature [4]. There are two different modes of intus-
susceptive angiogenesis. According to the first model, 
endothelial cells of the opposite vessel walls establish 
contact because of the pressure generated by connective 
tissue cells or pericytes; this is followed by the reorgani-
zation of intercellular junctions leading to the perforation 
of the endothelial bilayer. Collagen-producing cells enter 
the perforation in the vessel lumen. These cells and the 
synthesized collagen build up the connective tissue pillar 
in the lumen of the vessel (1–5 µm in diameter), which is 
a characteristic of intussusceptive angiogenesis. Further 
growth of the pillar results in the complete division of the 
lumen [4].
The formation of intraluminal pillars may also occur by 
another mechanism, the first step of which is the forma-
tion of endothelial bridges in the lumen. Here, degrada-
tion of the basement membrane takes place, and bridging 
endothelial cells attach to connective tissue collagen bun-
dles and transport them through the lumen. The collagen 
bundles are covered by endothelial cells; thus, initially, 
the nascent pillars are built up by two endothelial cells 
and a single collagen bundle. Fibroblasts migrate into this 
pillar and synthesize additional connective tissue, which 
results in pillar maturation [8]. Of note, similar to sprout-
ing angiogenesis (model two; see above), the polarity of 
endothelial cells does not change in either case. Accord-
ingly, this type of pillar formation can be called inverse 
sprouting since the connective tissue (surrounded by the 
endothelium) is located in the vessel lumen. In contrast, 
during sprouting angiogenesis, the lumen is located in 
the connective tissue.
Numerous schematic depictions in various studies sug-
gested that, during vascularization, the nearby vessels 
grow into the tumor [1, 9, 10]. However, in 1987, Thomp-
son et  al. [11] found that mouse tumors grow by incor-
porating the host tissue microvasculature. A subsequent 
human study by Pezzella et  al. [12] in 1997 confirmed 
the phenomenon of vessel incorporation in “non-angi-
ogenic” primary non-small cell lung cancers. Subse-
quently, our research group proved in experimental and 
human melanomas that vessels that develop by sprouting 
angiogenesis in the connective tissue surrounding the 
tumors become incorporated. Because of the growth of 
the tumor, the vessel density of the incorporated vas-
cular network decreases (becomes diluted) [13]. This 
phenomenon occurs because of the lack of branching 
activity of the intratumoral vessels. The low proliferation 
of endothelial cells solely supports the dilatation of the 
tumoral vessels [13]. An insufficient amount of collagen-
containing connective tissue within the tumors results 
in the termination of sprouting angiogenesis. In both 
human and experimental melanomas, the capillary net-
work is arranged in parallel with the surface of the tumor. 
This phenomenon itself supports the notion that melano-
mas do not acquire their vasculature by vessel ingrowth 
[13].
Vascularization of metastases
In clinical oncology, treatment of metastases is a great 
challenge. Angiogenesis is a possible target for the treat-
ment of tumors. Since the most frequent sites for metas-
tasis formation (the brain, liver, and lung) contain dense 
capillary networks and a relatively small amount of con-
nective tissue, it is likely that vascularization of metasta-
ses develops differently from primary tumors.
The brain
It is widely accepted that angiogenesis occurs in primary 
and metastatic brain tumors and in other pathologic 
disorders [14]. It has been reported that vascularization 
of metastases can occur by the incorporation of brain 
capillaries [15]. We analyzed the vascularization of 
experimental brain metastases in detail using five dif-
ferent tumor cell lines. Tumor cells were inoculated 
directly into the brain parenchyma to enable tumors to 
reach the size at which angiogenic switch is thought to 
occur (1  mm3). We found no new vessel formation in 
the close vicinity of tumors. Vessel density and bromo-
deoxyuridine (BrdU) labeling index of vascular cells did 
not change significantly. Tumors became vascularized 
exclusively by the incorporation of host vessels (Fig. 1a). 
During incorporation, the tumor mass “flowed” around 
the vessels while tumor cells detached astrocytes from 
their surfaces. The growth pattern of the metastases is 
associated with the number and size of incorporated ves-
sels. Tumors with infiltrative growth incorporated more 
vessels than expansively growing tumors (pushing type). 
We also found a negative correlation between the intratu-
moral vessel density and BrdU labeling index of vascular 
cells. Therefore, tumors with low levels of vessel incor-
poration may enhance blood supply by increasing vessel 
surface through vessel dilatation [16].
Glomeruloid bodies (GBs) are characteristics mainly 
of primary brain tumors, but they appear in brain 
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metastases and in other tumors as well [17]. GBs 
acquired their name because of their superficial resem-
blance to renal glomeruli. Until recently, the mechanism 
of GB formation was largely unknown. Stiver et  al. [18] 
performed a detailed analysis of GBs that were developed 
in a tumor-free environment using a VEGF-coding vector 
Fig. 1 Vessel incorporation and glomeruloid body formation in the brain. a Frozen section of an experimental brain metastasis of the C38 colo‑
rectal carcinoma cell line. The section is stained for CD31 (vessels, green), laminin (basement membrane, red), and 4′,6‑diamidino‑2‑phenylindole 
(DAPI; cell nuclei, blue). The DAPI staining shows that the tumor is located in the upper part of the picture. Arrowheads show the tumorparenchyma 
interface. The tumor mass “flows” around the vessels, thereby incorporating them (arrows). Vessel density is significantly lower and vessel diameter 
is larger in the intratumoral region than in the peritumoral tissue. Scale bar 100 µm. b Glomeruloid body formation after injection of tumor cells into 
the carotid artery. Simple loops (arrowheads) of the capillary (laminin, green) that develop in the vicinity of tumor cells (arrows) can be observed. 
Cell nuclei are stained by propidium iodide (red). Scale bar 20 µm. c Semi‑thin cross section stained by toluidine‑blue represents a glomeruloid body 
formed in a colony of human melanoma cells. There are several capillary lumens within the small tumor cell group. Scale bar 20 µm
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injected into brain tissue. The first step in the process was 
the appearance of dilated mother vessels. In the vessel 
wall, pericytes and endothelial cells started to proliferate 
and formed numerous lumens within the lumen of the 
mother vessel. Next, these structures differentiated into 
distinct daughter vessels through apoptosis of endothelial 
cells. Our group described another much simpler process 
in brain micrometastases [19]. According to this model, 
after injection of tumor cells into the carotid artery, 
tumor cells extravasate and adhere to the external surface 
of the basement membrane of capillaries. Following this, 
even a single cell is able to produce simple loops on capil-
laries (Fig. 1b), presumably because of the forces exerted 
by the actin cytoskeleton of tumor cells attached tightly 
to the surface of the basement membrane. Later, the 
force exerted by the proliferating and migrating tumor 
cells results in the appearance of more complex GBs as 
tumor cells pull new vessel segments into the tumor nests 
(Fig. 1c). This process leads to the thinning and eventual 
rupturing of capillary segments located between tumor 
nests. Proliferation of endothelial cells is only slightly ele-
vated during this process; therefore, the increase of the 
vessel density is simply the consequence of the remod-
eling of the existing vasculature in the brain tissue.
The liver
Vermeulen et  al. [20] described liver metastases with 
different growth patterns. The first type is the so-called 
“replacement” growth pattern where the liver struc-
ture is preserved and the liver trabeculae are replaced 
by tumor cells. In the second important growth pattern 
(“pushing”), the liver structure is distorted, liver cells on 
the surface of metastases are compressed, and connec-
tive tissue is deposited around the tumor. Replacement 
growth is a characteristic of undifferentiated metastases, 
whereas pushing growth is a characteristic of differenti-
ated metastases.
We examined experimental liver metastases that were 
produced by the injection of Lewis lung carcinoma cells 
into the spleen of C57Bl/6 mice. In this model, tumor 
cells reached the liver via the portal vein and formed 
colonies. Our studies on anaplastic Lewis lung carcinoma 
liver metastases showed that tumor cells migrated in the 
space of Disse during the invasion, at the tumor periph-
ery, thereby detaching the endothelial cells from their 
basement membrane (structured basement membrane 
could not be observed in the sinusoids, but immunoelec-
tron microscopic observations revealed several basement 
membrane elements between the microvilli of hepato-
cytes) [21]. Endothelial cells that get into the tumors 
start to proliferate and form functional vessels with wide 
lumen and vulnerable, convoluted walls (sinusoidal type 
metastases) [21]. We also observed another type of Lewis 
lung carcinoma metastasis that was located in portal 
spaces or in their close vicinity (portal-type metastases). 
These metastases are characterized by numerous small 
vessels that stained positively for basement membrane 
components. These vessels presumably evolved during 
sprouting angiogenesis within the connective tissue of 
portal spaces. Notably, the ratio of portal-type metasta-
ses was higher when tumor cells reached the liver via the 
arterial system. However, tumor cells entering the liver 
from the direction of the portal system produced more 
sinusoidal metastases. These results suggest that a pro-
portion of the tumor cells delivered via the arterial route 
are more likely to be trapped in the capillaries of the peri-
biliary plexus [21].
Our analysis of the pushing-type metastases produced 
by using C38 colon carcinoma cells showed that even in 
the early stages of metastasis development, proliferation 
of myofibroblasts and accumulation of connective tissue 
occur in the close vicinity of the metastases [22]. In par-
allel, liver cells are displaced, which leads to the fusion of 
sinusoids on the surface of the liver metastases (Fig. 2a, 
b). Fused sinusoids become incorporated together with 
the connective tissue, and the inner part of the invagina-
tion is pinched off by the tumor tissue. As a result, con-
nective tissue columns containing a central vessel will 
appear; these structures are able to provide blood supply 
for the tumor. Tumor cells surround these structures in 
a polarized manner and synthesize basement membrane 
onto the surface of the connective tissue (Fig. 2b).
Finally, it is noteworthy that in neither sinusoidal 
(replacement) nor pushing-type metastases does angio-
genesis take place in the peritumoral liver parenchyma.
The lung
In earlier studies, we found that the default growth type 
of experimental lung metastases is the “flow” of prolifer-
ating tumor cells from alveolus to alveolus [23] (Fig. 3a, 
b). This process leads to the formation of the alveolar pat-
tern in primary human and metastatic lung tumors (non-
angiogenic tumors), described previously by Pezzella 
et al. [12, 24]. Note that in the intact lung tissue around 
the metastases, proliferation of endothelial cells only 
slightly increases. This suggests that angiogenesis does 
not occur in this region. However, we found that vascu-
larization of tumors is not completed by the occupation 
of the alveoli. Instead, it continues by different mecha-
nisms in undifferentiated versus differentiated (desmo-
plastic) tumors [23].
Cells of undifferentiated tumors enter into the alveolar 
walls, and during their invasion/migration they detach 
pneumocytes from the surface of capillaries (Fig.  3c). 
As a result, tumor cells co-opt the capillaries that were 
formerly responsible for the gas exchange. Incorporated 
Page 5 of 8Bugyik et al. Chin J Cancer  (2016) 35:19 
capillaries remain functional and provide blood supply 
for the tumor. Interestingly, tumor cells detach pneumo-
cytes from the capillaries together with their basement 
membrane; thus, tumor cells actually migrate between 
the endothelial and epithelial basement membranes 
(Fig.  3d). Of note, the presence of basement membrane 
is not sufficient to support the survival of pneumocytes, 
which vanish by fragmentation within the tumor tissue.
Polarized tumor cells of well-differentiated C38 colon 
tumor do not migrate back into the alveolar walls from 
the alveolar space; instead, they induce a desmoplastic 
reaction in the alveolar wall. During this reaction, the 
fibroblasts present in the alveolar wall are transformed 
into smooth muscle actin (SMA)-expressing and connec-
tive tissue collagen-synthesizing myofibroblasts. Alveolar 
walls being incorporated into the tumor gradually widen, 
resulting in the development of connective tissue col-
umns (centrally located microvessels embedded in con-
nective tissue collagen and SMA-expressing activated 
fibroblasts surrounded by a basement membrane). The 
structure of these columns corresponds completely to the 
structure of connective tissue columns in the liver metas-
tases of this same tumor (Fig. 2b). The accumulated con-
nective tissue within the metastases and the significantly 
elevated proliferation index of intratumoral endothelial 
cells may indicate the initiation of angiogenesis within 
the columns.
Blood supply of metastases
In organs with dual blood supply (the liver and lung), 
the origin of the blood supply of metastases has been 
long debated. Most analyses have been done in the liver 
(including both animal and human samples). These 
experiments were performed by the injection of colored 
resin or India ink into the vasculature [25–27]. How-
ever, these studies neglected the relation of the arte-
rial to the portal system and the anatomical differences 
between murine and human liver. Contrary to the human 
liver, mouse and rat livers have an extensive system of 
anastomoses between the arterial and portal system at 
Fig. 2 Vascularization and connective tissue column formation in C38 liver metastases. a Scanning electron microscopic micrograph of the vas‑
culature of an experimental colorectal carcinoma metastasis in the liver after corrosion casting. On the upper-right side can normal structure of the 
sinusoidal system be observed (arrowheads). Sinusoidal lakes (asterisk) developed by fusion of the sinusoids can be observed close to the surface 
of the tumor. Arrows point at vessels supplying the metastasis. These structures correspond to the structure labeled by CD31 on Fig. 2b. Scale bar 
100 µm. b The structure of (blood supply‑providing) connective tissue columns in liver metastases. CD31‑positive vessel (green) is located centrally 
and surrounded by smooth muscle actin (red)‑expressing cells. The structure is surrounded by basement membrane (laminin, blue) deposited by 
tumor cells. Basement membrane (laminin, blue) of the central vessel can also be observed. Tumor cells (not stained) are located in the black areas. 
Scale bar 10 µm
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every level of the vascular network. Moreover, rat lung 
has anastomoses between the bronchial and pulmo-
nary arteries as well, which makes it difficult to deter-
mine the origin of blood supply. This problem can be 
solved by injecting casting solution into the portal vein 
or pulmonary artery up to the sinusoids or capillaries 
observed on the surface of the organs so the anastomo-
ses between the two systems are blocked. Under these 
conditions, the resin injected into the arterial system will 
appear only in metastases that are directly connected 
to arterioles or arteries (Fig. 4a). We observed that liver 
metastases larger than 2.5 mm in diameter become arte-
rially supplied [28]. However, in rat lung metastases, the 
bronchial artery is responsible for the blood supply of 
metastases larger than 5 mm only [23]. Supplying arteries 
are located mainly centrally, so it is likely that the blood 
flows from the center to the periphery (Fig. 4b). The dif-
ference regarding the tumor size in these two organs may 
be owing to the fact that, in the rat lung, bronchial arter-
ies do not expand to the periphery of the lung, so the 
metastases growing in this organ reach the arterial sys-
tem only when they get larger. The key step in the process 
of arterialization may be that low-pressure vessels (portal 
and central veins and pulmonary arteries and veins) are 
pushed aside by the tumor mass, whereas elements of 
the high-pressure arterial system become incorporated. 
Fig. 3 Vascularization of lung metastases. a Frozen section of a colorectal carcinoma metastasis in the lung. CD31 (vessels, green) and laminin 
(basement membrane, red) show that normal lung parenchyma is present (left side) next to the tumor tissue (right side). Tumor tissue is recognizable 
(pale-red) because of the laminin deposited by tumor cells. Alveoli are filled by tumor cells to different extents (asterisks). Scale bar 200 µm. b The 
peripheral region of a lung metastasis. Alveolar structure is preserved, and capillaries (CD31, green) are located within the alveolar walls (laminin, 
blue; arrows). The alveolar spaces are filled by tumor cells (propidium iodide, red). Scale bar 20 µm. c Lung metastasis of B16 melanoma cells. Tumor 
cells are stained by TOTO‑3 (blue). Tumor cells (small arrows) can be observed between pneumocytes (podoplanin, green) and the vessel wall (CD31, 
red). The alveolar structure is mostly disintegrated; however, intact alveolar walls still can be observed (large arrows). Asterisk shows the original 
alveolar lumen filled by tumor cells. Denuded vessels (small arrowheads) and vessel‑free pneumocytes (large arrowheads) are located within the 
tumor tissue. Scale bar 20 µm. d High‑power confocal image of a lung metastasis. This figure shows that both the detached pneumocytes (podopla‑
nin, green; arrows) and the vessel (CD31, blue; arrowheads) have their own basement membrane (laminin, red), and tumor cells are located between 
them. Scale bar 20 µm
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Consequently, regarding delivery of chemotherapeutic 
agents into the metastases, the arterial system may play 
an important role in both organs.
Conclusions
We conclude that the incorporation of both the preex-
isting host vasculature (which can be modified by the 
tumor) and the newly formed vessels plays an important 
role in the vascularization of tumors. The incorporation 
process is basically biomechanical in nature. We think 
that anti-angiogenic therapies should be given mainly 
to patients with primary tumors in which endothelial 
proliferation is present. The perimetastatic region can-
not be targeted by anti-angiogenic therapies because 
angiogenesis does not occur in the adjacent host tissues 
of tumor metastases (possibly because of the lack of suf-
ficient connective tissue). However, when sufficient con-
nective tissue is synthesized in the more central part of 
the lesions in a later phase of metastasis development, 
intratumoral angiogenesis is possible. This requires the 
presence of connective tissue cells in the target organ 
that are able to transform into collagen-synthesizing 
myofibroblasts.
Authors’ contributions
SP is the corresponding author. SP, EB, FRV, and BD wrote the manuscript. SP, 
PN, FRV, and BD participated in study design and coordinated and supervised 
the study. EB, VSZ, KD, NE, and AR collected the samples, carried out the exper‑
iments, and interpreted the data. All authors made important contributions to 
Fig. 4 Blood supply of liver metastases. a Stereomicroscopic image of colorectal carcinoma liver metastases after two colored casting procedure. 
Blue resin was injected into the portal vein and red resin was injected into the arterial system. Smaller metastases supplied by the portal system 
appear white (since the portal system was filled up to the level of terminal portal venules, the resin does not enter the sinusoids and, consequently, 
it does not enter the small metastases). Red resin appears in metastases that are in direct connection with the arterial system. Note that all of these 
metastases are larger than those that appear white. Scale bar 1 mm. b An arterial metastasis after corrosion of liver tissue. The artery (red) runs next 
to the portal venule (blue) and enters the metastasis (small arrowheads) centrally (arrow). Moderate dilatation of the artery can be observed near the 
entry site (arrow). The red resin injected into the arterial system appears also in the central vein (large arrowhead). Scale bar 100 µm
Page 8 of 8Bugyik et al. Chin J Cancer  (2016) 35:19 
the conception and design of the study and reviewed the results. All authors 
read and approved the final manuscript.
Author details
1 1st Department of Pathology and Experimental Cancer Research, Semmel‑
weis University, Üllői út 26, Budapest 1085, Hungary. 2 Department of Thoracic 
Surgery, Semmelweis University‑National Institute of Oncology, Buda‑
pest 1122, Hungary. 3 Hungarian Academy of Sciences Postdoctoral Research 
Programme, Budapest 1051, Hungary. 4 Department of Thoracic Surgery, 
Medical University of Vienna, 1090 Vienna, Austria. 5 Department of Bio‑
medical Imaging and Image‑guided Therapy, Medical University of Vienna, 
1090 Vienna, Austria. 6 Tumor Progression Research Group, Joint Research 
Organization of the Hungarian Academy of Sciences and Semmelweis Univer‑
sity, Budapest, Hungary. 
Acknowledgements
The study was supported by the Grants from KTIA AIK 12‑1‑2013‑0041; 
Semmelweis University Start‑Up Grant 40148‑11658; OTKA K109626, OTKA 
SNN114490, OTKA K100931, OTKA PD109201, EUREKA_HU_12‑1‑2012‑0057; 
TÁMOP 4.2.4.A/1‑11‑1‑2012‑0001; ÖNB Jubiläumsfondsprojekt Nr. 14043 
and Nr. 14574, and the Vienna Fund for Innovative Interdisciplinary Cancer 
Research.
Competing interests
The authors declare that they have no competing interests.
Received: 7 October 2015   Accepted: 6 January 2016
References
 1. Folkman J, Cotran R. Relation of vascular proliferation to tumor growth. 
Int Rev Exp Pathol. 1976;16:207–48.
 2. Sennino B, McDonald DM. Controlling escape from angiogenesis inhibi‑
tors. Nat Rev Cancer. 2012;12(10):699–709. doi:10.1038/nrc3366.
 3. Vasudev NS, Reynolds AR. Anti‑angiogenic therapy for cancer: current 
progress, unresolved questions and future directions. Angiogenesis. 
2014;17(3):471–94. doi:10.1007/s10456‑014‑9420‑y.
 4. Burri PH, Hlushchuk R, Djonov V. Intussusceptive angiogenesis: its emer‑
gence, its characteristics, and its significance. Dev Dyn. 2004;231(3):474–
88. doi:10.1002/dvdy.20184.
 5. Dvorak HF. Rous‑Whipple Award Lecture. How tumors make bad blood 
vessels and stroma. Am J Pathol. 2003;162(6):1747–57.
 6. Folkman J. Tumor angiogenesis. Adv Cancer Res. 1985;43:175–203.
 7. Paku S, Paweletz N. First steps of tumor‑related angiogenesis. Lab Invest. 
1991;65(3):334–46.
 8. Paku S, Dezso K, Bugyik E, Tovari J, Timar J, Nagy P, et al. A new mechanism 
for pillar formation during tumor‑induced intussusceptive angiogen‑
esis: inverse sprouting. Am J Pathol. 2011;179(3):1573–85. doi:10.1016/j.
ajpath.2011.05.033.
 9. Gordon MS, Mendelson DS, Kato G. Tumor angiogenesis and novel 
antiangiogenic strategies. Int J Cancer. 2010;126(8):1777–87. doi:10.1002/
ijc.25026.
 10. Stoeltzing O, Liu W, Reinmuth N, Parikh A, Ahmad SA, Jung YD, et al. 
Angiogenesis and antiangiogenic therapy of colon cancer liver metasta‑
sis. Ann Surg Oncol. 2003;10(7):722–33.
 11. Thompson WD, Shiach KJ, Fraser RA, McIntosh LC, Simpson JG. Tumours 
acquire their vasculature by vessel incorporation, not vessel ingrowth. J 
Pathol. 1987;151(4):323–32. doi:10.1002/path.1711510413.
 12. Pezzella F, Pastorino U, Tagliabue E, Andreola S, Sozzi G, Gasparini G, et al. 
Non‑small‑cell lung carcinoma tumor growth without morphological 
evidence of neo‑angiogenesis. Am J Pathol. 1997;151(5):1417–23.
 13. Dome B, Paku S, Somlai B, Timar J. Vascularization of cutaneous mela‑
noma involves vessel co‑option and has clinical significance. J Pathol. 
2002;197(3):355–62. doi:10.1002/path.1124.
 14. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor 
TT. Angiogenesis in brain tumours. Nat Rev Cancer. 2007;8(8):610–22. 
doi:10.1038/nrn2175.
 15. Leenders WP, Kusters B, Verrijp K, Maass C, Wesseling P, Heerschap A, 
et al. Antiangiogenic therapy of cerebral melanoma metastases results 
in sustained tumor progression via vessel co‑option. Clin Cancer Res. 
2004;10(18 Pt 1):6222–30. doi:10.1158/1078‑0432.CCR‑04‑0823.
 16. Bugyik E, Dezso K, Reiniger L, Laszlo V, Tovari J, Timar J, et al. Lack of angio‑
genesis in experimental brain metastases. J Neuropathol Exp Neurol. 
2011;70(11):979–91. doi:10.1097/NEN.0b013e318233afd7.
 17. Straume O, Chappuis PO, Salvesen HB, Halvorsen OJ, Haukaas SA, Goffin 
JR, et al. Prognostic importance of glomeruloid microvascular prolifera‑
tion indicates an aggressive angiogenic phenotype in human cancers. 
Cancer Res. 2002;62(23):6808–11.
 18. Stiver SI, Tan X, Brown LF, Hedley‑Whyte ET, Dvorak HF. VEGF‑A angiogen‑
esis induces a stable neovasculature in adult murine brain. J Neuropathol 
Exp Neurol. 2004;63(8):841–55.
 19. Dome B, Timar J, Paku S. A novel concept of glomeruloid body forma‑
tion in experimental cerebral metastases. J Neuropathol Exp Neurol. 
2003;62(6):655–61.
 20. Vermeulen PB, Colpaert C, Salgado R, Royers R, Hellemans H, Van Den 
Heuvel E, et al. Liver metastases from colorectal adenocarcinomas grow 
in three patterns with different angiogenesis and desmoplasia. J Pathol. 
2001;195(3):336–42. doi:10.1002/path.966.
 21. Paku S, Lapis K. Morphological aspects of angiogenesis in experimental 
liver metastases. Am J Pathol. 1993;143(3):926–36.
 22. Paku S, Kopper L, Nagy P. Development of the vasculature in “pushing‑
type” liver metastases of an experimental colorectal cancer. Int J Cancer. 
2005;115(6):893–902. doi:10.1002/ijc.20886.
 23. Szabo V, Bugyik E, Dezso K, Ecker N, Nagy P, Timar J, et al. Mechanism 
of tumour vascularization in experimental lung metastases. J Pathol. 
2015;235(3):384–96. doi:10.1002/path.4464.
 24. Pezzella F, Di Bacco A, Andreola S, Nicholson AG, Pastorino U, Harris AL. 
Angiogenesis in primary lung cancer and lung secondaries. Eur J Cancer. 
1996;32A(14):2494–500.
 25. Lin G, Lunderquist A, Hagerstrand I, Boijsen E. Postmortem examination 
of the blood supply and vascular pattern of small liver metastases in man. 
Surgery. 1984;96(3):517–26.
 26. Haugeberg G, Strohmeyer T, Lierse W, Bocker W. The vascularization 
of liver metastases. Histological investigation of gelatine‑injected liver 
specimens with special regard to the vascularization of micrometastases. 
J Cancer Res Clin Oncol. 1988;114(4):415–9.
 27. Kuruppu D, Christophi C, O’Brien PE. Microvascular architecture of hepatic 
metastases in a mouse model. HPB Surg. 1997;10(3):149–57; (discussion 
58).
 28. Dezso K, Bugyik E, Papp V, Laszlo V, Dome B, Tovari J, et al. Development 
of arterial blood supply in experimental liver metastases. Am J Pathol. 
2009;175(2):835–43. doi:10.2353/ajpath.2009.090095.
